All treatments are delivered discreetly and professionally in the comfort of your own home
This South-Korea based pharma was a major leader in GLP-1 development during the 2010s, alongside Eli Lilly and Novo Nordisk, developing three different GLP-1 drugs: Efpeglenatide, a once-weekly GLP-1 agonist, Efinopegdutide, a once-weekly GLP-1/Glucagon dual agonist, and HM15211, a once-weekly GLP-1/GIP/Glucagon triple agonist
There is no large, independent, placebo-controlled trial establishing that copper peptides regrow scalp hair the way minoxidil and finasteride have been shown to
Bac water fits that category because its benzyl alcohol is there to support that preserved status
All production follows established laboratory protocols ensuring consistent batch-to-batch quality